Skip to main content

HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil.

Wludarski SC, Lopes LF, Berto E Silva TR, Carvalho FM, Weiss LM, Bacchi CE

Publication: Appl Immunohistochem Mol Morphol (2011) • Vol 19 • Page 112-8PMID: 20930616View on PubMed

Purpose

The purpose of this paper was to compare HER2 immunohistochemical (IHC) and fluorescence in-situ hybridization (FISH) results in breast cancer tissue specimens.

Conclusion

FISH and IHC staining results showed overall concordance rates of 98.4% for HER2 positive and negative specimens. Very low concordance rates were found between a reference laboratory and local laboratories for HER2 IHC analysis.

Studies (1)

Purpose

The purpose of this study was to compare HER2 IHC and FISH results for breast carcinoma specimens and to determine factors leading to discordant IHC results between reference and local laboratories.

Summary of Findings

Out of 2000 specimens examined, FISH results were inconclusive for 218 specimens predominantly due to inadequate preservation of tissue. Overall concordance was 98.4% for HER2 positive and negative cases by IHC and FISH. Specimens found to be HER2 equivocal by IHC staining were negative (nonamplified) for HER-2 by FISH 69.8% of the time and positive (amplified) by FISH 30.2% of the time. Between the reference laboratory and local laboratories, HER2 immunostaining results were concordant 6.2%, 14.0%, 84.9%, and 43.8% of the time for scores of 0, 1+, 2+, and 3+, respectively. 27 of the 247 cases (10.9%) scored as 0 or 1+ (negative) by the reference laboratory were scored as 3+ (positive) by local laboratories, and an additional 173 of these cases (70.0%) were scored as 2+ (equivocal) by local laboratories. Of note, information regarding the antibodies used for HER2 IHC analysis was not provided by 55.8% of the local laboratories, while all specimens were analyzed with the SP3 antibody at the reference laboratory. Further, information about fixative and fixation time was not provided by 62.6% of the local laboratories.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    DNAFISH
    MorphologyLight microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    FISH SpecificTargeted nucleic acid
    HER2
    Immunohistochemistry SpecificTargeted peptide/protein
    HER2
    Immunohistochemistry SpecificTechnology platform
    FISH
    Immunohistochemistry SpecificType of antibody
    10A7
    5A2
    A0485
    CB11
    CBE1
    DAKO polyclonal
    EP1045Y
    HER-24
    HercepTest
    SP3
    TAB250
    Unspecified
    Unspecified polyclonal